Fampridine Sustained-Release Tablets (Fampyra) is a prescription medication indicated for improving walking ability in patients with multiple sclerosis (MS). Patients are most concerned about its purchase channels, precautions for use, and methods to distinguish genuine drugs from counterfeits.
What Are the Purchase Channels for Fampridine Sustained-Release Tablets (Fampyra)?
Overseas Purchase
Patients may opt to consult and purchase the medication at hospital pharmacies or licensed drugstores in countries or regions where Fampridine Sustained-Release Tablets have been marketed.
Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.
Purchase via Medical Service Institutions
Patients can consult domestic overseas medical service institutions that have partnerships with international pharmacies or pharmaceutical manufacturers.
These institutions can usually provide legal import channels as well as professional consultation and guidance.
Precautions for Purchasing and Using Fampridine Sustained-Release Tablets (Fampyra)
Prescription Requirement
This is a prescription-only drug and must be used under the guidance of a physician. Patients shall not purchase or adjust the dosage on their own.
Administration Method
The tablets should be swallowed whole and must not be split, crushed, chewed or dissolved.
Otherwise, the sustained-release structure will be destroyed, leading to an immediate large release of the drug, which can easily trigger seizures.
Dosage and Missed Dose
The maximum recommended dosage is one tablet (10 mg) twice daily, taken approximately 12 hours apart.
If a dose is missed, do not double the dose at the next administration. Instead, skip the missed dose and take the next dose at the scheduled time.
Contraindicated Populations
The use of Fampridine Sustained-Release Tablets is strictly prohibited in patients with a history of epilepsy, moderate to severe renal insufficiency (creatinine clearance ≤ 50 mL/min), or a known hypersensitivity to Fampridine Sustained-Release Tablets or its active ingredient 4-aminopyridine.
How to Distinguish Genuine Fampridine Sustained-Release Tablets (Fampyra) from Counterfeits?
Packaging Material and Printing
The packaging material of genuine drugs is usually of high quality, smooth to the touch without roughness.
The printing is clear, the color is uniform, and the text is accurate without typos.
Label Information
The label of legitimate drugs contains complete information, including drug name, specification, manufacturer, production date, expiration date, etc., and all details are accurate.
The label of counterfeit drugs may have incomplete or incorrect information.
Tablet Appearance
Observe whether the color, shape and size of the tablets are uniform.
The texture of genuine tablets is consistent, while counterfeit ones may show inconsistencies.
Sealing Condition
The packaging of genuine drugs is tightly sealed without damage or signs of being opened.
Counterfeit drugs may have poor sealing.
